PDT Partners, LLC - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 169 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$371,394
+169.1%
88,008
+28.6%
0.05%
+123.8%
Q3 2022$138,000
-66.7%
68,449
-47.4%
0.02%
-43.2%
Q2 2022$414,000
-27.5%
130,130
-4.9%
0.04%
-24.5%
Q1 2022$571,000
+7.7%
136,816
+23.7%
0.05%
+22.5%
Q4 2021$530,000
+188.0%
110,566
+207.0%
0.04%
+233.3%
Q2 2021$184,00036,0200.01%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$83,503,0007.34%
Eversept Partners, LP 2,656,208$10,306,0872.29%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$62,908,0001.13%
Prosight Management, LP 512,659$1,989,0000.95%
THB ASSET MANAGEMENT 833,104$3,232,0000.90%
GLOBEFLEX CAPITAL L P 251,696$977,0000.26%
XTX MARKETS LLC 10,243$40,0000.19%
HUSSMAN STRATEGIC ADVISORS, INC. 102,000$396,0000.10%
PA Capital LLC 33,874$132,0000.09%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 60,900$236,0000.07%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders